Home › NDC Lookup › RxCUI directory › RxCUI 997010

Quinine sulfate 324 MG Oral Capsule — RxCUI 997010

RxNorm drug concept · Semantic clinical drug
RxCUI 997010 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI997010
Official nameQuinine sulfate 324 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped6
Reported Medicaid activity (SDUD)401 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Quinine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Quinine sulfate capsules are prescribed to treat a specific type of malaria caused by the Plasmodium falciparum parasite. The amount of quinine in tonic water is tiny compared to a...
  • Why was I prescribed quinine — I thought it was just in tonic water?
  • Almost everyone taking quinine gets what's called cinchonism — a cluster of side effects that includes ringing in the ears, headache, nausea, dizziness, and sometimes blurred visio...
  • What side effects should I expect while taking this?
📖 Read our full Quinine guide →

🕸️ Concept Web — How Quinine sulfate 324 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Quinine sulfate 324 MG Oral Capsule RxCUI 997010

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Quinine 9071
    • Quinine sulfate 9075
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Qualaquin 647128
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Quinine Oral Capsule 373744
    • Quinine sulfate Oral Capsule 2648341
    • Quinine Oral Product 1164190
    • Quinine Pill 1164191
    • Quinine sulfate Oral Product 2659165
    • Quinine sulfate Pill 2660215
    • Quinine Oral Capsule [Qualaquin] 647130
    • Quinine sulfate Oral Capsule [Qualaquin] 2655411
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Quinine sulfate 324 MG 997009
    • Quinine sulfate 324 MG Oral Capsule [Qualaquin] 997012
    • Quinine sulfate 324 MG [Qualaquin] 997011

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Quinine sulfate 324 MG SCDC · 997009
  • Quinine Oral Capsule SCDF · 373744
  • Quinine sulfate Oral Capsule SCDFP · 2648341
  • Quinine Oral Product SCDG · 1164190
  • Quinine Pill SCDG · 1164191
  • Quinine sulfate Oral Product SCDGP · 2659165
  • Quinine sulfate Pill SCDGP · 2660215

Brand-Name Concepts

  • Quinine sulfate 324 MG Oral Capsule [Qualaquin] SBD · 997012
  • Quinine sulfate 324 MG [Qualaquin] SBDC · 997011
  • Quinine Oral Capsule [Qualaquin] SBDF · 647130
  • Quinine sulfate Oral Capsule [Qualaquin] SBDFP · 2655411
  • Qualaquin Oral Product SBDG · 1185311
  • Qualaquin Pill SBDG · 1185312
  • Qualaquin BN · 647128

📦 FDA Products & Package NDCs

4 products · 6 package NDCs
6 package NDCs map to RxCUI 997010 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-3002-56 30 CAPSULE in 1 BOTTLE (0093-3002-56) Quinine Sulfate Teva Pharmaceuticals USA, Inc. 2012-09-28
50742-0238-30 30 CAPSULE in 1 BOTTLE, PLASTIC (50742-238-30) QUININE SULFATE Ingenus Pharmaceuticals, LLC 2017-12-11
65162-0811-03 30 CAPSULE in 1 BOTTLE (65162-811-03) Quinine Sulfate Amneal Pharmaceuticals LLC 2016-07-29
65162-0811-09 90 CAPSULE in 1 BOTTLE (65162-811-09) Quinine Sulfate Amneal Pharmaceuticals LLC 2016-07-29
65162-0811-50 500 CAPSULE in 1 BOTTLE (65162-811-50) Quinine Sulfate Amneal Pharmaceuticals LLC 2016-07-29
68180-0560-06 30 CAPSULE in 1 BOTTLE (68180-560-06) QUININE SULFATE Lupin Pharmaceuticals, Inc. 2015-08-04
Observed labelers: Amneal Pharmaceuticals LLC (3) · Ingenus Pharmaceuticals, LLC (1) · Lupin Pharmaceuticals, Inc. (1) · Teva Pharmaceuticals USA, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.7200
Range $0.7200–$0.7200 · middle 50% $0.7200–$0.7200 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.